BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

222 related articles for article (PubMed ID: 2116115)

  • 1. Small intestinal permeability and orocaecal transit time in cystic fibrosis.
    Dalzell AM; Freestone NS; Billington D; Heaf DP
    Arch Dis Child; 1990 Jun; 65(6):585-8. PubMed ID: 2116115
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intestinal permeability to 51Cr-EDTA and orocecal transit time in cystic fibrosis.
    Escobar H; Perdomo M; Vasconez F; Camarero C; del Olmo MT; Suárez L
    J Pediatr Gastroenterol Nutr; 1992 Feb; 14(2):204-7. PubMed ID: 1593376
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intestinal permeability and orocaecal transit time in elderly patients with Parkinson's disease.
    Davies KN; King D; Billington D; Barrett JA
    Postgrad Med J; 1996 Mar; 72(845):164-7. PubMed ID: 8731708
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prolonged small-intestinal transit time in cystic fibrosis.
    Bali A; Stableforth DE; Asquith P
    Br Med J (Clin Res Ed); 1983 Oct; 287(6398):1011-3. PubMed ID: 6412927
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Assessment of the Effect of Intestinal Permeability Probes (Lactulose And Mannitol) and Other Liquids on Digesta Residence Times in Various Segments of the Gut Determined by Wireless Motility Capsule: A Randomised Controlled Trial.
    Sequeira IR; Lentle RG; Kruger MC; Hurst RD
    PLoS One; 2015; 10(12):e0143690. PubMed ID: 26629926
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inulin is an ideal substrate for a hydrogen breath test to measure the orocaecal transit time.
    Geboes KP; Luypaerts A; Rutgeerts P; Verbeke K
    Aliment Pharmacol Ther; 2003 Oct; 18(7):721-9. PubMed ID: 14510746
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Modulation of orocaecal transit time by hypnosis.
    Beaugerie L; Burger AJ; Cadranel JF; Lamy P; Gendre JP; Le Quintrec Y
    Gut; 1991 Apr; 32(4):393-4. PubMed ID: 2026339
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intestinal permeability in children with Crohn's disease and coeliac disease.
    Pearson AD; Eastham EJ; Laker MF; Craft AW; Nelson R
    Br Med J (Clin Res Ed); 1982 Jul; 285(6334):20-1. PubMed ID: 6805795
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lactulose-rhamnose intestinal permeability in children with cystic fibrosis.
    Leclercq-Foucart J; Forget PP; Van Cutsem JL
    J Pediatr Gastroenterol Nutr; 1987; 6(1):66-70. PubMed ID: 3794935
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparison of orocaecal transit times assessed by the lactulose/breath hydrogen and the sulphasalazine/sulphapyridine methods.
    Staniforth DH
    Gut; 1989 Jul; 30(7):978-82. PubMed ID: 2569435
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Intestinal permeability in exocrine pancreatic insufficiency due to cystic fibrosis or chronic pancreatitis.
    van Elburg RM; Uil JJ; van Aalderen WM; Mulder CJ; Heymans HS
    Pediatr Res; 1996 Jun; 39(6):985-91. PubMed ID: 8725259
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Small intestinal permeability to sugars in patients with atopic eczema.
    Ukabam SO; Mann RJ; Cooper BT
    Br J Dermatol; 1984 Jun; 110(6):649-52. PubMed ID: 6428445
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Oro-caecal transit time and intra-luminal pH in cystic fibrosis patients with distal intestinal obstruction syndrome.
    Dalzell AM; Heaf DP
    Acta Univ Carol Med (Praha); 1990; 36(1-4):159-60. PubMed ID: 2130682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Small intestinal permeability in pediatric clinical practice.
    Hamilton I; Hill A; Bose B; Bouchier IA; Forsyth JS
    J Pediatr Gastroenterol Nutr; 1987; 6(5):697-701. PubMed ID: 3121835
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Small intestinal permeability in normal Sudanese subjects: evidence of tropical enteropathy.
    Ukabam SO; Homeida MM; Cooper BT
    Trans R Soc Trop Med Hyg; 1986; 80(2):204-7. PubMed ID: 3097886
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Statistical analysis of the lactulose/breath hydrogen test in the measurement of orocaecal transit: its variability and predictive value in assessing drug action.
    Staniforth DH; Rose D
    Gut; 1989 Feb; 30(2):171-5. PubMed ID: 2703140
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of orocaecal transit time on hydrogen excretion after carbohydrate malabsorption.
    Rumessen JJ; Hamberg O; Gudmand-Høyer E
    Gut; 1989 Jun; 30(6):811-4. PubMed ID: 2753406
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The lactulose hydrogen breath test as a measure of orocaecal transit time.
    Jorge JM; Wexner SD; Ehrenpreis ED
    Eur J Surg; 1994 Aug; 160(8):409-16. PubMed ID: 7811826
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Abnormal small intestinal permeability to sugars in patients with Crohn's disease of the terminal ileum and colon.
    Ukabam SO; Clamp JR; Cooper BT
    Digestion; 1983; 27(2):70-4. PubMed ID: 6414866
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Standardising the lactulose mannitol test of gut permeability to minimise error and promote comparability.
    Sequeira IR; Lentle RG; Kruger MC; Hurst RD
    PLoS One; 2014; 9(6):e99256. PubMed ID: 24901524
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.